Ustekinumab, sold under the brand name Stelara is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,targeting both IL-12 and IL-23.<\/p>\n
Ustekinumab is approved to treat Crohn’s disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not responded to more traditional treatments. It was found not effective for multiple sclerosis.<\/p>\n
If ustekinumab injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
STELARA (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
ustekinumab injection is a human interleukin-12 and -23 antagonist indicated for the treatment of adult patients with: \u2022 moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapy. \u2022 active psoriatic arthritis (PsA), alone or in combination with methotrexate. \u2022 moderately to severely active Crohn\u2019s disease (CD).<\/p>\n
DISEASE INDICATIONS-Plaque Psoriasis, psoriatic arthritis, Crohn’s disease, or ulcerative colitis. If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201custekinumab injection\u201d based on the information you provide.<\/p>\n
\nMANUFACTURER-Janssen Pharmaceuticals
\nUSAGE-subcutaneous
\nMEDICINE APPROVED BY-The European Medicines Agency (EMA), Food and Drug Administration (FDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n